Clinical trial Recruiting at 2 sites Interventional Ages 45 to 75

Fusion versus decompression alone for single-level lumbar stenosis

Official title: Necessity of Fusion Following Decompression Surgery in Patients With Single-level Lumbar Stenosis: Study Protocol for an Open-label Multicenter Non-inferiority Randomized Controlled Clinical Trial

Run by Sklifosovsky Institute of Emergency Care · NCT05273879 · Data updated 2026-11-12

This trial will test whether decompression surgery without added fusion works as well as decompression plus fusion for adults aged 45–75 with single-level lumbar spinal stenosis.

Quick facts

Study typeInterventional
Ages45 Years to 75 Years
SexAll
Enrollment86 (estimated)
SponsorSklifosovsky Institute of Emergency Care
Government
Locations2 sites (Moscow, Moscow and 1 other locations)
StatusRecruiting
StartedApril 1, 2022
Main results expectedDecember 30, 2026
Study endsDecember 30, 2026
Registry record updatedDecember 18, 2025
Trial IDNCT05273879 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 45–75 with single‑level (L2–S1) lumbar stenosis grade C or D on MRI, symptomatic neurogenic claudication or radiculopathy, failure of ≥3 months of conservative care, no prior spine surgery, and acceptable bone density and stability are ideal candidates.

Probably not a fit

Patients with multilevel clinically significant stenosis, prior spine surgery, spinal instability or spondylolisthesis >3 mm, significant sagittal imbalance, very low bone density (<100 HU), or ASA class 4–5 are unlikely to benefit from this comparison or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial will enroll 86 adults with single‑level lumbar stenosis and assign them 1:1 to decompression that preserves posterior elements or to decompression plus transforaminal interbody fusion. Surgeons will use a standardized operative protocol and postoperative rehabilitation to maximize homogeneity between groups. The primary outcome is change in the Oswestry Disability Index at 24 months, and secondary outcomes include SF‑36, EQ‑5D‑5L, psychological scales, sagittal balance, fusion status, and total cost over two years. Patients will be followed at 3, 6, 12, and 24 months to capture clinical, radiographic, and economic outcomes.

Why it matters

Potential benefit: If decompression alone proves non‑inferior, many patients could avoid fusion, reducing surgical risk, implant-related complications, and cost.

How similar studies have gone: Only one randomized trial about 15 years ago directly addressed this question, so randomized evidence is limited and the necessity of fusion remains controversial.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* age of patients from 45 to 75 years;
* stenosis C or D according to Shizas et al. according to MRI at the level of L2-L3, L3-L4, L4-L5 or L5-S1;
* clinical manifestations of lumbar stenosis (neurogenic claudication syndrome and/or radiculopathy);
* lack of effect from conservative therapy within 3 months;
* Informed consent to take part in the study.

Exclusion Criteria:

* spondylolisthesis more than 3 mm;
* spinal instability according to functional radiography;
* sagittal imbalance (type 4 according to C. Barrey);
* bone density of the vertebrae at the level of the operation is less than 100 HU;
* clinically significant spinal stenosis at 2 or more levels;
* previously performed surgeries on the spine;
* risk of anesthesia 4 or 5 according to ASA;
* inability to take part in control examinations within 2 years after the operation;
* participation in other clinical trials related to surgical or conservative treatment of diseases of the spine.

Where it's running

  • Pirogov National Medical and Surgical Center
    Moscow, Moscow, Russia
    Recruiting
  • Sklifosovsky Research Institute for Emergency Medicine
    Moscow, Moscow, Russia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.